Abstract

Our knowledge of nicotine-like receptors in brain, their distribution and functional importance is fragmentary. Most information has been obtained by using iontophoretic and electrophysiological techniques. The introduction of radio-receptor binding techniques has, however, increased the possibility of characterizing the nicotine-like binding sites in brain by using ligands with high specific radioactivity. It is well established that α-bungarotoxin (α-Btx) binds to the nicotine-like acetylcholine (ACh) receptor on electric organ of electric eel and ray and on skeletal muscle and functionally acts as an irreversible antagonist. Binding of α-Btx to various nervous tissues such as sympathetic ganglia, retina and brain have been reported (for review, see 5), but it has not yet been proved that this binding is to a functionally active ACh receptor binding site (2,3,8). For nicotine receptor binding studies in brain, α-Btx has been used by most investigators (5), but in a few studies other ligands such as nicotine (1,7,10,17), and the nicotinic antagonist tubocurarine (1,7) have been used.KeywordsSympathetic GanglionReceptor Binding SiteElectric OrganHuman Fetal BrainHuman HippocampusThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.